Wendy Perrow
Geen lopende functies
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Patricia Russo | F | 71 | 29 jaar | |
Peter Wendell | M | 73 | 21 jaar | |
Steven Altschuler | M | 70 |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | 5 jaar |
Caroline Litchfield | F | 55 | 34 jaar | |
Christine Thomas | F | 51 | 2 jaar | |
Sapna R. Srivastava | M | 53 |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | 5 jaar |
Dov Elefant | M | 56 | 2 jaar | |
James Matteucci | M | - | 21 jaar | |
Joshua Barer | M | - |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | 6 jaar |
Alistair Milnes | M | 50 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Robert P. Luciano | M | - | 23 jaar | |
Richard Kogan | M | 81 | 21 jaar | |
Kenneth Frazier | M | 69 | 30 jaar | |
P. Vagelos | M | 94 | 19 jaar | |
Bruce Peacock | M | 72 |
Alba Therapeutics Corp.
Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | - |
Raymond Gilmartin | M | 82 | 2 jaar | |
Fred Hassan | M | 78 | 6 jaar | |
Jeffrey Church | M | 67 |
Alba Therapeutics Corp.
Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | 3 jaar |
David Anstice | M | 75 | 5 jaar | |
Joseph Romanelli | M | 50 | 19 jaar | |
Thomas Shenk | M | 77 | 11 jaar | |
Donald S. Brooks | M | 88 | - | |
Anne Tatlock | F | 84 | - | |
Richard Markham | M | 73 | 20 jaar | |
Wendy Yarno | F | 69 | 9 jaar | |
Marino Carol | F | - | 8 jaar | |
John Adams | M | 62 | 8 jaar | |
Ismail Kola | M | 67 | 4 jaar | |
David Gionco | M | 63 | 3 jaar | |
Gary Thompson | M | 67 | 12 jaar | |
Kevin M. Slawin | M | 63 |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | - |
William Harrison | M | 80 | - | |
Larry G. Edwards | M | 52 | 15 jaar | |
Laura Sepp-Lorenzino | M | 63 | 15 jaar | |
William B. Witte | M | 61 | 5 jaar | |
Anne Morrissey | F | 57 | 2 jaar | |
John Dyett | M | 54 | 6 jaar | |
Jacob Harel | M | 69 | 13 jaar | |
Joe Pedersen | M | - | 23 jaar | |
Carole A. Sable | M | 62 | 12 jaar | |
Mark Bach | M | 67 | 17 jaar | |
Christine Bunt | F | - | 7 jaar | |
Dorothy P. Bowers | F | - | - | |
Berta Strulovici | M | - | - | |
David A. Esposito | M | 55 | 13 jaar | |
James Villalobos | M | 55 | - | |
Silvana Battaglia | F | 56 | 10 jaar | |
Kimberly Murphy | F | 62 | 6 jaar | |
Judith C. Seltz | F | 61 | 15 jaar | |
Jens Renstrup | M | 59 | 8 jaar | |
Eric Schadt | M | 59 | 8 jaar | |
Desiree Ralls-Morrison | F | 57 | 8 jaar | |
Benito Munoz | M | 62 | 9 jaar | |
Arthur Santora | M | 73 | 28 jaar | |
François Meurgey | M | - | - | |
Simon D. Kelner | M | 51 | 13 jaar | |
Ernesto Aycardi | M | 61 | 11 jaar | |
Kevin J. Horgan | M | 64 | 8 jaar | |
Zhi Sheng Chen | M | 52 | 5 jaar | |
Glenn Williams | M | - | 10 jaar | |
Juan Camilo Arjona Ferreira | M | 54 | 12 jaar | |
James S. MacDonald | M | - | 17 jaar | |
Lisa Escudero | F | 62 | 18 jaar | |
Barbara Yanni | F | 69 | 13 jaar | |
Frank Verwiel | M | 62 | 4 jaar | |
Jim Hinrichs | M | 56 | 5 jaar | |
Nolan Sigal | M | 73 | 10 jaar | |
Heidi Miller | M | 70 | 4 jaar | |
Philippe Schaison | M | 62 | 7 jaar | |
Barry Gumbiner | M | 68 | 6 jaar | |
Mark E. McDonough | M | 59 | - | |
Timothy Proctor | M | 74 | 13 jaar | |
James Christopher Scalet | M | 65 | 9 jaar | |
Peter G. Ernster | M | 82 | 26 jaar | |
Samuel O. Thier | M | 86 | 16 jaar | |
Joan Wainwright | F | 63 | 6 jaar | |
Marcia Avedon | M | 62 | 4 jaar | |
Stephen Gold | M | 65 | 2 jaar | |
Elizabeth Hamilton Seabury Wyatt | M | 76 | 20 jaar | |
Robert Segal | M | 66 | - | |
George Morrow | M | 72 | 11 jaar | |
Larry Bossidy | M | 89 | 14 jaar | |
Abraham E. Cohen | M | 86 | 10 jaar | |
Lars Kåre Viksmoen | M | 75 | 14 jaar | |
Gregory S. Patrick | M | 72 | 14 jaar | |
Thomas J. Ouellette | M | - | 16 jaar | |
Gary T. Shearman | M | - | 5 jaar | |
Gerald J. Gallivan | M | - | - | |
Horace D. Nalle | M | - | - | |
Zofia E. Dziewanowska | M | 82 | - | |
Michael Atieh | M | 70 | 19 jaar | |
Jean-Michael Halfon | M | 72 | 2 jaar | |
Michael Tarnow | M | 79 | 22 jaar | |
Guy MacDonald | M | 65 | 22 jaar | |
Ronald B. Moss | M | 64 | 1 jaar | |
Jeffrey A. Peris | M | 77 | 25 jaar | |
Vijay Samant | M | 77 | 23 jaar | |
Margaret McGlynn | F | 64 | 11 jaar | |
Jerome C. Keller | M | 81 | 7 jaar | |
Yaacov Weinstock | M | - | 1 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 100 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Wendy Perrow
- Persoonlijk netwerk